Naidoo
Early in her career, Kogie was one of the first clinicians to provide antiretroviral therapy to people living with HIV in South Africa, and to offer free antiretrovirals in clinics in rural South Africa. However, these efforts then revealed the enormous death toll of TB in the country. Since then, she has devoted her life to finding ways to reduce the burden of TB and HIV co-infections.
Her work has focused on disease prevention, vaccine trials and implementation research, particularly around drug-resistant TB. A particularly notable achievement was work demonstrating more than a halving of mortality in HIV/TB co-infected patients.
Prof. Naidoo was presented the award at the Eleventh EDCTP Forum Opening Ceremony by Sylvie Retailleau, French Minister for Research, Higher Education and Innovation.
scroll down
Read more
The Outstanding Female Scientist Prize is awarded to world-class female scientists working in sub-Saharan Africa in the scope of the EDCTP2 programme. Prize-winners are recognised for their significant scientific contributions and achievements in their research field as well as their efforts at building research capacity through training and mentorship of the future generation of researchers and scientists in Africa.
scroll down
Naidoo
The Outstanding Female Scientist Prize is awarded to world-class female scientists working in sub-Saharan Africa in the scope of the EDCTP2 programme. Prize-winners are recognised for their significant scientific contributions and achievements in their research field as well as their efforts at building research capacity through training and mentorship of the future generation of researchers and scientists in Africa.
Read more
Early in her career, Kogie was one of the first clinicians to provide antiretroviral therapy to people living with HIV in South Africa, and to offer free antiretrovirals in clinics in rural South Africa. However, these efforts then revealed the enormous death toll of TB in the country. Since then, she has devoted her life to finding ways to reduce the burden of TB and HIV co-infections.
Her work has focused on disease prevention, vaccine trials and implementation research, particularly around drug-resistant TB. A particularly notable achievement was work demonstrating more than a halving of mortality in HIV/TB co-infected patients.
Prof. Naidoo was presented the award at the Eleventh EDCTP Forum Opening Ceremony by Sylvie Retailleau, French Minister for Research, Higher Education and Innovation.